Boston University
Increasing skeletal muscle mass reduces systemic insulin resistance and obesity-related hippocampal dysfunction
Abstract
dc:description.abstractType 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia, impaired insulin sensitivity, and central and peripheral insulin resistance (IR), with obesity being the primary risk factor. Obesity-associated central IR disrupts hippocampal insulin signaling, which is required for synaptic plasticity and cognition, contributing to cognitive decline and dementia-related neuropathology. Skeletal muscle is the primary location of postprandial glucose disposal and communicates with the brain by endocrine-mediated signaling via the exchange of exercise-induced myokines that regulate hippocampal plasticity and cognition. However, it remains unclear whether increasing skeletal muscle mass to reduce peripheral IR can alleviate obesity-related hippocampal dysfunction. This study investigated whether pharmacologically inducing skeletal muscle hypertrophy would attenuate obesity-related hippocampal dysfunction driven by central IR. Male C57BL/6J mice were fed either a control (CD) or high-fat high-sucrose (HFHS) diet for 16 consecutive weeks, and were provided 10 doses of either placebo or CDD866 (murinized bimagrumab) from Week 12 – 16. Metabolic cages recorded ambulatory (locomotor) and stereotypy activity. Hindlimb skeletal muscle quantification and body composition were measured via quadriceps muscle weight, microCT, and EchoMRI. Anxiety-like behavior and spatial working memory were observed via elevated zero maze (EZM) and Morris water maze (MWM), respectively. Whole-body metabolism was assessed via fasting blood glucose, fasting plasma insulin, and HOMA-IR. The unilateral hippocampus was dissected and neuronal insulin signaling was assessed with qPCR. HFHS feeding increased body weight, induced peripheral IR, reduced locomotor activity, increased anxiety-like behaviors, and impaired spatial working memory. CDD866 induced skeletal muscle hypertrophy, improved body composition, reduced peripheral IR, reduced locomotor activity and stereotypic behavior, and improved spatial working memory, despite having minimal effects on anxiety-like behaviors. Total brain weight was unchanged across groups. Hippocampal expression of insulin signaling genes was largely unchanged, but CDD866 reduced Pdk4 expression in HFHS-fed mice and increased Akt1 expression in CD-fed mice. These findings suggest that diet-induced obesity and peripheral IR impair hippocampal plasticity and cognition, and that pharmacologically-induced skeletal muscle hypertrophy improves whole-body metabolism and is associated with improved cognitive function. Although changes in hippocampal gene expression were modest, the behavioral improvements support further investigation into skeletal muscle brain crosstalk as a potential therapeutic in obesity-related cognitive impairments and dementias.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Anatomy & Neurobiology
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Mirrione, Sophia M.
- Advisor dc:contributor.advisor
-
- Luptak, Ivan
- ORCID dc:identifier.orcid
Subjects
dc:subject × 8Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53478